Irish Irish
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Nuacht is Déanaí

Ag scrúdú peirspictíochtaí othar agus gairmiúla sa RA maidir le géinteiripe i haemaifilia

 

Fógraíonn BioMarin Rialú Bleed Bliantúil Cobhsaí agus Marthanach sa Staidéar Teiripe Géin Chéim 3 is Mó i nDaoine Fásta a bhfuil Haemaifilia Tromchúiseach A acu

 

Teiripe Géine Valoctocogene Roxaparvovec le haghaidh Haemaifilia A

 

Buaileann Teiripe Haemophilia B Gene UniQure, CSL Príomhsprioc Staidéar Chéim III

 

Ar ais go barr
Íomha

Please enable the javascript to submit this form

Maidir

Le tacaíocht ó dheontais oideachais ó Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, agus uniQure, Inc.

Riachtanach SSL